Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years: An open-label trial

This open-label study was designed to assess immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) when administered to Japanese adults aged ≥50 years not previously vaccinated with 23-valent pneumococcal polysaccharide vaccine and to compare this Japanese study population wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiramoto, Masanari, Irie, Shin, Juergens, Christine, Yamaji, Masako, Tamai, Satoshi, Aizawa, Masakazu, Belanger, Todd, Gruber, William C, Scott, Daniel A, Schmoele-Thoma, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186023/
https://www.ncbi.nlm.nih.gov/pubmed/25424792
http://dx.doi.org/10.4161/hv.28633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186023/
https://www.ncbi.nlm.nih.gov/pubmed/25424792
http://dx.doi.org/10.4161/hv.28633

Ejemplares similares